Moreover, it has been indicated that inhibiting AQP4 improved patient outcome and neurological function, reduced infarction volume, increased neuronal survival, and reduced apoptosis and the inflammatory response after cerebral ischemia, which was in accordance with brain edema reduction [8]. The gene discussed is AQP4; the disease is brain ischemia.